| The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells AS Meyer, MA Miller, FB Gertler, DA Lauffenburger Science signaling 6 (287), ra66-ra66, 2013 | 292 | 2013 |
| Reduced proteolytic shedding of receptor tyrosine kinases is a post-translational mechanism of kinase inhibitor resistance MA Miller, MJ Oudin, RJ Sullivan, SJ Wang, AS Meyer, H Im, DT Frederick, ... Cancer discovery 6 (4), 382-399, 2016 | 175 | 2016 |
| 2D protrusion but not motility predicts growth factor–induced cancer cell migration in 3D collagen AS Meyer, SK Hughes-Alford, JE Kay, A Castillo, A Wells, FB Gertler, ... Journal of Cell Biology 197 (6), 721-729, 2012 | 135 | 2012 |
| Human induced pluripotent stem cell-derived glial cells and neural progenitors display divergent responses to Zika and dengue infections J Muffat, Y Li, A Omer, A Durbin, I Bosch, G Bakiasi, E Richards, A Meyer, ... Proceedings of the National Academy of Sciences 115 (27), 7117-7122, 2018 | 121 | 2018 |
| ADAM-10 and-17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling MA Miller, AS Meyer, MT Beste, Z Lasisi, S Reddy, KW Jeng, CH Chen, ... Proceedings of the National Academy of Sciences 110 (22), E2074-E2083, 2013 | 103 | 2013 |
| An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence CH Lee, TH Kang, O Godon, M Watanabe, G Delidakis, CM Gillis, ... Nature communications 10 (1), 5031, 2019 | 66 | 2019 |
| Concentration of mammalian genomic DNA using two‐phase aqueous micellar systems F Mashayekhi, AS Meyer, SA Shiigi, V Nguyen, DT Kamei Biotechnology and bioengineering 102 (6), 1613-1623, 2009 | 56 | 2009 |
| A requirement for filopodia extension toward Slit during Robo-mediated axon repulsion RE McConnell, J Edward van Veen, M Vidaki, AV Kwiatkowski, AS Meyer, ... Journal of Cell Biology 213 (2), 261-274, 2016 | 55 | 2016 |
| The AXL receptor is a sensor of ligand spatial heterogeneity AS Meyer, AJM Zweemer, DA Lauffenburger Cell systems 1 (1), 25-36, 2015 | 53 | 2015 |
| A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance AD Schwartz, LE Barney, LE Jansen, TV Nguyen, CL Hall, AS Meyer, ... Integrative Biology 9 (12), 912-924, 2017 | 46 | 2017 |
| Impact of the 2014 American Academy of Pediatrics immunoprophylaxis policy on the rate, severity, and cost of respiratory syncytial virus hospitalizations among preterm infants LR Krilov, J Fergie, M Goldstein, L Brannman American journal of perinatology 37 (02), 174-183, 2020 | 36 | 2020 |
| Dissecting FcγR regulation through a multivalent binding model RA Robinett, N Guan, A Lux, M Biburger, F Nimmerjahn, AS Meyer Cell systems 7 (1), 41-48. e5, 2018 | 35 | 2018 |
| Apoptotic bodies elicit Gas6-mediated migration of AXL-expressing tumor cells AJM Zweemer, CB French, J Mesfin, S Gordonov, AS Meyer, ... Molecular Cancer Research 15 (12), 1656-1666, 2017 | 34 | 2017 |
| Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain MA Miller, ML Moss, G Powell, R Petrovich, L Edwards, AS Meyer, ... Scientific reports 5 (1), 15150, 2015 | 33 | 2015 |
| Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts HD Kim, AS Meyer, JP Wagner, SK Alford, A Wells, FB Gertler, ... Molecular & Cellular Proteomics 10 (11), 2011 | 33 | 2011 |
| Systems approaches to cancer biology TC Archer, EJ Fertig, SJC Gosline, M Hafner, SK Hughes, BA Joughin, ... Cancer research 76 (23), 6774-6777, 2016 | 30 | 2016 |
| Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection D VanDyke, M Iglesias, J Tomala, A Young, J Smith, JA Perry, E Gebara, ... Cell reports 41 (3), 2022 | 26 | 2022 |
| Selectivity in subunit composition of Ena/VASP tetramers DN Riquelme, AS Meyer, M Barzik, A Keating, FB Gertler Bioscience reports 35 (5), e00246, 2015 | 24 | 2015 |
| Systems biology approaches to measure and model phenotypic heterogeneity in cancer AS Meyer, LM Heiser Current opinion in systems biology 17, 35-40, 2019 | 21 | 2019 |
| JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2–Targeted Therapies S Manole, EJ Richards, AS Meyer Cancer research 76 (18), 5219-5228, 2016 | 21 | 2016 |
Douglas LauffenburgerMIT在 mit.edu 的电子邮件经过验证
